Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Veterinary Anthrax Vaccines Market Growth 2022-2028

  • LP 4873230
  • 108 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Veterinary Anthrax Vaccines will have significant change from previous year. According to our (LP Information) latest study, the global Veterinary Anthrax Vaccines market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Veterinary Anthrax Vaccines market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Veterinary Anthrax Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Veterinary Anthrax Vaccines market, reaching US$ million by the year 2028. As for the Europe Veterinary Anthrax Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Veterinary Anthrax Vaccines players cover Agrovet, Bayer Sanidad Animal, Biogenesis Bago SA, and Botswana Vaccine Institute, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Anthrax Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Cell Free PA Vaccines

Live Vaccines

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Cow

Sheep

Swine

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Agrovet

Bayer Sanidad Animal

Biogenesis Bago SA

Botswana Vaccine Institute

Central Veterinary Control and Research Institute

Centro Diagnostico Veterinario

Ceva Sante Animale

Colorado Serum Company

Empresa Colombiana de Productos Veterinarios S.A

Indian Immunologicals Limited

Institute for Biological Products

Intervac(PVT) Ltd

JOVAC

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Veterinary Anthrax Vaccines Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Veterinary Anthrax Vaccines by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Veterinary Anthrax Vaccines by Country/Region, 2017, 2022 & 2028

2.2 Veterinary Anthrax Vaccines Segment by Type

2.2.1 Cell Free PA Vaccines

2.2.2 Live Vaccines

2.3 Veterinary Anthrax Vaccines Sales by Type

2.3.1 Global Veterinary Anthrax Vaccines Sales Market Share by Type (2017-2022)

2.3.2 Global Veterinary Anthrax Vaccines Revenue and Market Share by Type (2017-2022)

2.3.3 Global Veterinary Anthrax Vaccines Sale Price by Type (2017-2022)

2.4 Veterinary Anthrax Vaccines Segment by Application

2.4.1 Cow

2.4.2 Sheep

2.4.3 Swine

2.4.4 Other

2.5 Veterinary Anthrax Vaccines Sales by Application

2.5.1 Global Veterinary Anthrax Vaccines Sale Market Share by Application (2017-2022)

2.5.2 Global Veterinary Anthrax Vaccines Revenue and Market Share by Application (2017-2022)

2.5.3 Global Veterinary Anthrax Vaccines Sale Price by Application (2017-2022)

3 Global Veterinary Anthrax Vaccines by Company

3.1 Global Veterinary Anthrax Vaccines Breakdown Data by Company

3.1.1 Global Veterinary Anthrax Vaccines Annual Sales by Company (2020-2022)

3.1.2 Global Veterinary Anthrax Vaccines Sales Market Share by Company (2020-2022)

3.2 Global Veterinary Anthrax Vaccines Annual Revenue by Company (2020-2022)

3.2.1 Global Veterinary Anthrax Vaccines Revenue by Company (2020-2022)

3.2.2 Global Veterinary Anthrax Vaccines Revenue Market Share by Company (2020-2022)

3.3 Global Veterinary Anthrax Vaccines Sale Price by Company

3.4 Key Manufacturers Veterinary Anthrax Vaccines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Veterinary Anthrax Vaccines Product Location Distribution

3.4.2 Players Veterinary Anthrax Vaccines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Veterinary Anthrax Vaccines by Geographic Region

4.1 World Historic Veterinary Anthrax Vaccines Market Size by Geographic Region (2017-2022)

4.1.1 Global Veterinary Anthrax Vaccines Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Veterinary Anthrax Vaccines Annual Revenue by Geographic Region

4.2 World Historic Veterinary Anthrax Vaccines Market Size by Country/Region (2017-2022)

4.2.1 Global Veterinary Anthrax Vaccines Annual Sales by Country/Region (2017-2022)

4.2.2 Global Veterinary Anthrax Vaccines Annual Revenue by Country/Region

4.3 Americas Veterinary Anthrax Vaccines Sales Growth

4.4 APAC Veterinary Anthrax Vaccines Sales Growth

4.5 Europe Veterinary Anthrax Vaccines Sales Growth

4.6 Middle East & Africa Veterinary Anthrax Vaccines Sales Growth

5 Americas

5.1 Americas Veterinary Anthrax Vaccines Sales by Country

5.1.1 Americas Veterinary Anthrax Vaccines Sales by Country (2017-2022)

5.1.2 Americas Veterinary Anthrax Vaccines Revenue by Country (2017-2022)

5.2 Americas Veterinary Anthrax Vaccines Sales by Type

5.3 Americas Veterinary Anthrax Vaccines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Veterinary Anthrax Vaccines Sales by Region

6.1.1 APAC Veterinary Anthrax Vaccines Sales by Region (2017-2022)

6.1.2 APAC Veterinary Anthrax Vaccines Revenue by Region (2017-2022)

6.2 APAC Veterinary Anthrax Vaccines Sales by Type

6.3 APAC Veterinary Anthrax Vaccines Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Veterinary Anthrax Vaccines by Country

7.1.1 Europe Veterinary Anthrax Vaccines Sales by Country (2017-2022)

7.1.2 Europe Veterinary Anthrax Vaccines Revenue by Country (2017-2022)

7.2 Europe Veterinary Anthrax Vaccines Sales by Type

7.3 Europe Veterinary Anthrax Vaccines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Veterinary Anthrax Vaccines by Country

8.1.1 Middle East & Africa Veterinary Anthrax Vaccines Sales by Country (2017-2022)

8.1.2 Middle East & Africa Veterinary Anthrax Vaccines Revenue by Country (2017-2022)

8.2 Middle East & Africa Veterinary Anthrax Vaccines Sales by Type

8.3 Middle East & Africa Veterinary Anthrax Vaccines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Veterinary Anthrax Vaccines

10.3 Manufacturing Process Analysis of Veterinary Anthrax Vaccines

10.4 Industry Chain Structure of Veterinary Anthrax Vaccines

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Veterinary Anthrax Vaccines Distributors

11.3 Veterinary Anthrax Vaccines Customer

12 World Forecast Review for Veterinary Anthrax Vaccines by Geographic Region

12.1 Global Veterinary Anthrax Vaccines Market Size Forecast by Region

12.1.1 Global Veterinary Anthrax Vaccines Forecast by Region (2023-2028)

12.1.2 Global Veterinary Anthrax Vaccines Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Veterinary Anthrax Vaccines Forecast by Type

12.7 Global Veterinary Anthrax Vaccines Forecast by Application

13 Key Players Analysis

13.1 Agrovet

13.1.1 Agrovet Company Information

13.1.2 Agrovet Veterinary Anthrax Vaccines Product Offered

13.1.3 Agrovet Veterinary Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Agrovet Main Business Overview

13.1.5 Agrovet Latest Developments

13.2 Bayer Sanidad Animal

13.2.1 Bayer Sanidad Animal Company Information

13.2.2 Bayer Sanidad Animal Veterinary Anthrax Vaccines Product Offered

13.2.3 Bayer Sanidad Animal Veterinary Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Bayer Sanidad Animal Main Business Overview

13.2.5 Bayer Sanidad Animal Latest Developments

13.3 Biogenesis Bago SA

13.3.1 Biogenesis Bago SA Company Information

13.3.2 Biogenesis Bago SA Veterinary Anthrax Vaccines Product Offered

13.3.3 Biogenesis Bago SA Veterinary Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Biogenesis Bago SA Main Business Overview

13.3.5 Biogenesis Bago SA Latest Developments

13.4 Botswana Vaccine Institute

13.4.1 Botswana Vaccine Institute Company Information

13.4.2 Botswana Vaccine Institute Veterinary Anthrax Vaccines Product Offered

13.4.3 Botswana Vaccine Institute Veterinary Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Botswana Vaccine Institute Main Business Overview

13.4.5 Botswana Vaccine Institute Latest Developments

13.5 Central Veterinary Control and Research Institute

13.5.1 Central Veterinary Control and Research Institute Company Information

13.5.2 Central Veterinary Control and Research Institute Veterinary Anthrax Vaccines Product Offered

13.5.3 Central Veterinary Control and Research Institute Veterinary Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Central Veterinary Control and Research Institute Main Business Overview

13.5.5 Central Veterinary Control and Research Institute Latest Developments

13.6 Centro Diagnostico Veterinario

13.6.1 Centro Diagnostico Veterinario Company Information

13.6.2 Centro Diagnostico Veterinario Veterinary Anthrax Vaccines Product Offered

13.6.3 Centro Diagnostico Veterinario Veterinary Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Centro Diagnostico Veterinario Main Business Overview

13.6.5 Centro Diagnostico Veterinario Latest Developments

13.7 Ceva Sante Animale

13.7.1 Ceva Sante Animale Company Information

13.7.2 Ceva Sante Animale Veterinary Anthrax Vaccines Product Offered

13.7.3 Ceva Sante Animale Veterinary Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Ceva Sante Animale Main Business Overview

13.7.5 Ceva Sante Animale Latest Developments

13.8 Colorado Serum Company

13.8.1 Colorado Serum Company Company Information

13.8.2 Colorado Serum Company Veterinary Anthrax Vaccines Product Offered

13.8.3 Colorado Serum Company Veterinary Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Colorado Serum Company Main Business Overview

13.8.5 Colorado Serum Company Latest Developments

13.9 Empresa Colombiana de Productos Veterinarios S.A

13.9.1 Empresa Colombiana de Productos Veterinarios S.A Company Information

13.9.2 Empresa Colombiana de Productos Veterinarios S.A Veterinary Anthrax Vaccines Product Offered

13.9.3 Empresa Colombiana de Productos Veterinarios S.A Veterinary Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Empresa Colombiana de Productos Veterinarios S.A Main Business Overview

13.9.5 Empresa Colombiana de Productos Veterinarios S.A Latest Developments

13.10 Indian Immunologicals Limited

13.10.1 Indian Immunologicals Limited Company Information

13.10.2 Indian Immunologicals Limited Veterinary Anthrax Vaccines Product Offered

13.10.3 Indian Immunologicals Limited Veterinary Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Indian Immunologicals Limited Main Business Overview

13.10.5 Indian Immunologicals Limited Latest Developments

13.11 Institute for Biological Products

13.11.1 Institute for Biological Products Company Information

13.11.2 Institute for Biological Products Veterinary Anthrax Vaccines Product Offered

13.11.3 Institute for Biological Products Veterinary Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Institute for Biological Products Main Business Overview

13.11.5 Institute for Biological Products Latest Developments

13.12 Intervac(PVT) Ltd

13.12.1 Intervac(PVT) Ltd Company Information

13.12.2 Intervac(PVT) Ltd Veterinary Anthrax Vaccines Product Offered

13.12.3 Intervac(PVT) Ltd Veterinary Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Intervac(PVT) Ltd Main Business Overview

13.12.5 Intervac(PVT) Ltd Latest Developments

13.13 JOVAC

13.13.1 JOVAC Company Information

13.13.2 JOVAC Veterinary Anthrax Vaccines Product Offered

13.13.3 JOVAC Veterinary Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 JOVAC Main Business Overview

13.13.5 JOVAC Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Veterinary Anthrax Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Veterinary Anthrax Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Cell Free PA Vaccines

Table 4. Major Players of Live Vaccines

Table 5. Global Veterinary Anthrax Vaccines Sales by Type (2017-2022) & (K Pcs)

Table 6. Global Veterinary Anthrax Vaccines Sales Market Share by Type (2017-2022)

Table 7. Global Veterinary Anthrax Vaccines Revenue by Type (2017-2022) & ($ million)

Table 8. Global Veterinary Anthrax Vaccines Revenue Market Share by Type (2017-2022)

Table 9. Global Veterinary Anthrax Vaccines Sale Price by Type (2017-2022) & (USD/Pcs)

Table 10. Global Veterinary Anthrax Vaccines Sales by Application (2017-2022) & (K Pcs)

Table 11. Global Veterinary Anthrax Vaccines Sales Market Share by Application (2017-2022)

Table 12. Global Veterinary Anthrax Vaccines Revenue by Application (2017-2022)

Table 13. Global Veterinary Anthrax Vaccines Revenue Market Share by Application (2017-2022)

Table 14. Global Veterinary Anthrax Vaccines Sale Price by Application (2017-2022) & (USD/Pcs)

Table 15. Global Veterinary Anthrax Vaccines Sales by Company (2020-2022) & (K Pcs)

Table 16. Global Veterinary Anthrax Vaccines Sales Market Share by Company (2020-2022)

Table 17. Global Veterinary Anthrax Vaccines Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Veterinary Anthrax Vaccines Revenue Market Share by Company (2020-2022)

Table 19. Global Veterinary Anthrax Vaccines Sale Price by Company (2020-2022) & (USD/Pcs)

Table 20. Key Manufacturers Veterinary Anthrax Vaccines Producing Area Distribution and Sales Area

Table 21. Players Veterinary Anthrax Vaccines Products Offered

Table 22. Veterinary Anthrax Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Veterinary Anthrax Vaccines Sales by Geographic Region (2017-2022) & (K Pcs)

Table 26. Global Veterinary Anthrax Vaccines Sales Market Share Geographic Region (2017-2022)

Table 27. Global Veterinary Anthrax Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Veterinary Anthrax Vaccines Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Veterinary Anthrax Vaccines Sales by Country/Region (2017-2022) & (K Pcs)

Table 30. Global Veterinary Anthrax Vaccines Sales Market Share by Country/Region (2017-2022)

Table 31. Global Veterinary Anthrax Vaccines Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Veterinary Anthrax Vaccines Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Veterinary Anthrax Vaccines Sales by Country (2017-2022) & (K Pcs)

Table 34. Americas Veterinary Anthrax Vaccines Sales Market Share by Country (2017-2022)

Table 35. Americas Veterinary Anthrax Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Veterinary Anthrax Vaccines Revenue Market Share by Country (2017-2022)

Table 37. Americas Veterinary Anthrax Vaccines Sales by Type (2017-2022) & (K Pcs)

Table 38. Americas Veterinary Anthrax Vaccines Sales Market Share by Type (2017-2022)

Table 39. Americas Veterinary Anthrax Vaccines Sales by Application (2017-2022) & (K Pcs)

Table 40. Americas Veterinary Anthrax Vaccines Sales Market Share by Application (2017-2022)

Table 41. APAC Veterinary Anthrax Vaccines Sales by Region (2017-2022) & (K Pcs)

Table 42. APAC Veterinary Anthrax Vaccines Sales Market Share by Region (2017-2022)

Table 43. APAC Veterinary Anthrax Vaccines Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Veterinary Anthrax Vaccines Revenue Market Share by Region (2017-2022)

Table 45. APAC Veterinary Anthrax Vaccines Sales by Type (2017-2022) & (K Pcs)

Table 46. APAC Veterinary Anthrax Vaccines Sales Market Share by Type (2017-2022)

Table 47. APAC Veterinary Anthrax Vaccines Sales by Application (2017-2022) & (K Pcs)

Table 48. APAC Veterinary Anthrax Vaccines Sales Market Share by Application (2017-2022)

Table 49. Europe Veterinary Anthrax Vaccines Sales by Country (2017-2022) & (K Pcs)

Table 50. Europe Veterinary Anthrax Vaccines Sales Market Share by Country (2017-2022)

Table 51. Europe Veterinary Anthrax Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Veterinary Anthrax Vaccines Revenue Market Share by Country (2017-2022)

Table 53. Europe Veterinary Anthrax Vaccines Sales by Type (2017-2022) & (K Pcs)

Table 54. Europe Veterinary Anthrax Vaccines Sales Market Share by Type (2017-2022)

Table 55. Europe Veterinary Anthrax Vaccines Sales by Application (2017-2022) & (K Pcs)

Table 56. Europe Veterinary Anthrax Vaccines Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Veterinary Anthrax Vaccines Sales by Country (2017-2022) & (K Pcs)

Table 58. Middle East & Africa Veterinary Anthrax Vaccines Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Veterinary Anthrax Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Veterinary Anthrax Vaccines Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Veterinary Anthrax Vaccines Sales by Type (2017-2022) & (K Pcs)

Table 62. Middle East & Africa Veterinary Anthrax Vaccines Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Veterinary Anthrax Vaccines Sales by Application (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Veterinary Anthrax Vaccines Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Veterinary Anthrax Vaccines

Table 66. Key Market Challenges & Risks of Veterinary Anthrax Vaccines

Table 67. Key Industry Trends of Veterinary Anthrax Vaccines

Table 68. Veterinary Anthrax Vaccines Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Veterinary Anthrax Vaccines Distributors List

Table 71. Veterinary Anthrax Vaccines Customer List

Table 72. Global Veterinary Anthrax Vaccines Sales Forecast by Region (2023-2028) & (K Pcs)

Table 73. Global Veterinary Anthrax Vaccines Sales Market Forecast by Region

Table 74. Global Veterinary Anthrax Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Veterinary Anthrax Vaccines Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Veterinary Anthrax Vaccines Sales Forecast by Country (2023-2028) & (K Pcs)

Table 77. Americas Veterinary Anthrax Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Veterinary Anthrax Vaccines Sales Forecast by Region (2023-2028) & (K Pcs)

Table 79. APAC Veterinary Anthrax Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Veterinary Anthrax Vaccines Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Europe Veterinary Anthrax Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Veterinary Anthrax Vaccines Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Middle East & Africa Veterinary Anthrax Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Veterinary Anthrax Vaccines Sales Forecast by Type (2023-2028) & (K Pcs)

Table 85. Global Veterinary Anthrax Vaccines Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Veterinary Anthrax Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Veterinary Anthrax Vaccines Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Veterinary Anthrax Vaccines Sales Forecast by Application (2023-2028) & (K Pcs)

Table 89. Global Veterinary Anthrax Vaccines Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Veterinary Anthrax Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Veterinary Anthrax Vaccines Revenue Market Share Forecast by Application (2023-2028)

Table 92. Agrovet Basic Information, Veterinary Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 93. Agrovet Veterinary Anthrax Vaccines Product Offered

Table 94. Agrovet Veterinary Anthrax Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 95. Agrovet Main Business

Table 96. Agrovet Latest Developments

Table 97. Bayer Sanidad Animal Basic Information, Veterinary Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 98. Bayer Sanidad Animal Veterinary Anthrax Vaccines Product Offered

Table 99. Bayer Sanidad Animal Veterinary Anthrax Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 100. Bayer Sanidad Animal Main Business

Table 101. Bayer Sanidad Animal Latest Developments

Table 102. Biogenesis Bago SA Basic Information, Veterinary Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 103. Biogenesis Bago SA Veterinary Anthrax Vaccines Product Offered

Table 104. Biogenesis Bago SA Veterinary Anthrax Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 105. Biogenesis Bago SA Main Business

Table 106. Biogenesis Bago SA Latest Developments

Table 107. Botswana Vaccine Institute Basic Information, Veterinary Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 108. Botswana Vaccine Institute Veterinary Anthrax Vaccines Product Offered

Table 109. Botswana Vaccine Institute Veterinary Anthrax Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 110. Botswana Vaccine Institute Main Business

Table 111. Botswana Vaccine Institute Latest Developments

Table 112. Central Veterinary Control and Research Institute Basic Information, Veterinary Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 113. Central Veterinary Control and Research Institute Veterinary Anthrax Vaccines Product Offered

Table 114. Central Veterinary Control and Research Institute Veterinary Anthrax Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 115. Central Veterinary Control and Research Institute Main Business

Table 116. Central Veterinary Control and Research Institute Latest Developments

Table 117. Centro Diagnostico Veterinario Basic Information, Veterinary Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 118. Centro Diagnostico Veterinario Veterinary Anthrax Vaccines Product Offered

Table 119. Centro Diagnostico Veterinario Veterinary Anthrax Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 120. Centro Diagnostico Veterinario Main Business

Table 121. Centro Diagnostico Veterinario Latest Developments

Table 122. Ceva Sante Animale Basic Information, Veterinary Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 123. Ceva Sante Animale Veterinary Anthrax Vaccines Product Offered

Table 124. Ceva Sante Animale Veterinary Anthrax Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 125. Ceva Sante Animale Main Business

Table 126. Ceva Sante Animale Latest Developments

Table 127. Colorado Serum Company Basic Information, Veterinary Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 128. Colorado Serum Company Veterinary Anthrax Vaccines Product Offered

Table 129. Colorado Serum Company Veterinary Anthrax Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 130. Colorado Serum Company Main Business

Table 131. Colorado Serum Company Latest Developments

Table 132. Empresa Colombiana de Productos Veterinarios S.A Basic Information, Veterinary Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 133. Empresa Colombiana de Productos Veterinarios S.A Veterinary Anthrax Vaccines Product Offered

Table 134. Empresa Colombiana de Productos Veterinarios S.A Veterinary Anthrax Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 135. Empresa Colombiana de Productos Veterinarios S.A Main Business

Table 136. Empresa Colombiana de Productos Veterinarios S.A Latest Developments

Table 137. Indian Immunologicals Limited Basic Information, Veterinary Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 138. Indian Immunologicals Limited Veterinary Anthrax Vaccines Product Offered

Table 139. Indian Immunologicals Limited Veterinary Anthrax Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 140. Indian Immunologicals Limited Main Business

Table 141. Indian Immunologicals Limited Latest Developments

Table 142. Institute for Biological Products Basic Information, Veterinary Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 143. Institute for Biological Products Veterinary Anthrax Vaccines Product Offered

Table 144. Institute for Biological Products Veterinary Anthrax Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 145. Institute for Biological Products Main Business

Table 146. Institute for Biological Products Latest Developments

Table 147. Intervac(PVT) Ltd Basic Information, Veterinary Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 148. Intervac(PVT) Ltd Veterinary Anthrax Vaccines Product Offered

Table 149. Intervac(PVT) Ltd Veterinary Anthrax Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 150. Intervac(PVT) Ltd Main Business

Table 151. Intervac(PVT) Ltd Latest Developments

Table 152. JOVAC Basic Information, Veterinary Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 153. JOVAC Veterinary Anthrax Vaccines Product Offered

Table 154. JOVAC Veterinary Anthrax Vaccines Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 155. JOVAC Main Business

Table 156. JOVAC Latest Developments

List of Figures

Figure 1. Picture of Veterinary Anthrax Vaccines

Figure 2. Veterinary Anthrax Vaccines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Veterinary Anthrax Vaccines Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Veterinary Anthrax Vaccines Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Veterinary Anthrax Vaccines Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Cell Free PA Vaccines

Figure 10. Product Picture of Live Vaccines

Figure 11. Global Veterinary Anthrax Vaccines Sales Market Share by Type in 2021

Figure 12. Global Veterinary Anthrax Vaccines Revenue Market Share by Type (2017-2022)

Figure 13. Veterinary Anthrax Vaccines Consumed in Cow

Figure 14. Global Veterinary Anthrax Vaccines Market: Cow (2017-2022) & (K Pcs)

Figure 15. Veterinary Anthrax Vaccines Consumed in Sheep

Figure 16. Global Veterinary Anthrax Vaccines Market: Sheep (2017-2022) & (K Pcs)

Figure 17. Veterinary Anthrax Vaccines Consumed in Swine

Figure 18. Global Veterinary Anthrax Vaccines Market: Swine (2017-2022) & (K Pcs)

Figure 19. Veterinary Anthrax Vaccines Consumed in Other

Figure 20. Global Veterinary Anthrax Vaccines Market: Other (2017-2022) & (K Pcs)

Figure 21. Global Veterinary Anthrax Vaccines Sales Market Share by Application (2017-2022)

Figure 22. Global Veterinary Anthrax Vaccines Revenue Market Share by Application in 2021

Figure 23. Veterinary Anthrax Vaccines Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Veterinary Anthrax Vaccines Revenue Market Share by Company in 2021

Figure 25. Global Veterinary Anthrax Vaccines Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Veterinary Anthrax Vaccines Revenue Market Share by Geographic Region in 2021

Figure 27. Global Veterinary Anthrax Vaccines Sales Market Share by Region (2017-2022)

Figure 28. Global Veterinary Anthrax Vaccines Revenue Market Share by Country/Region in 2021

Figure 29. Americas Veterinary Anthrax Vaccines Sales 2017-2022 (K Pcs)

Figure 30. Americas Veterinary Anthrax Vaccines Revenue 2017-2022 ($ Millions)

Figure 31. APAC Veterinary Anthrax Vaccines Sales 2017-2022 (K Pcs)

Figure 32. APAC Veterinary Anthrax Vaccines Revenue 2017-2022 ($ Millions)

Figure 33. Europe Veterinary Anthrax Vaccines Sales 2017-2022 (K Pcs)

Figure 34. Europe Veterinary Anthrax Vaccines Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Veterinary Anthrax Vaccines Sales 2017-2022 (K Pcs)

Figure 36. Middle East & Africa Veterinary Anthrax Vaccines Revenue 2017-2022 ($ Millions)

Figure 37. Americas Veterinary Anthrax Vaccines Sales Market Share by Country in 2021

Figure 38. Americas Veterinary Anthrax Vaccines Revenue Market Share by Country in 2021

Figure 39. United States Veterinary Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Veterinary Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Veterinary Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Veterinary Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Veterinary Anthrax Vaccines Sales Market Share by Region in 2021

Figure 44. APAC Veterinary Anthrax Vaccines Revenue Market Share by Regions in 2021

Figure 45. China Veterinary Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Veterinary Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Veterinary Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Veterinary Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Veterinary Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Veterinary Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Veterinary Anthrax Vaccines Sales Market Share by Country in 2021

Figure 52. Europe Veterinary Anthrax Vaccines Revenue Market Share by Country in 2021

Figure 53. Germany Veterinary Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Veterinary Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Veterinary Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Veterinary Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Veterinary Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Veterinary Anthrax Vaccines Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Veterinary Anthrax Vaccines Revenue Market Share by Country in 2021

Figure 60. Egypt Veterinary Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Veterinary Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Veterinary Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Veterinary Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Veterinary Anthrax Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Veterinary Anthrax Vaccines in 2021

Figure 66. Manufacturing Process Analysis of Veterinary Anthrax Vaccines

Figure 67. Industry Chain Structure of Veterinary Anthrax Vaccines

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390